ERBB2 and breast cancer: Recently, an accumulation of HER2-targeting mAb trastuzumab (Herceptin) in tumor-associated phagocytes was observed when the AlexFluor647-conjugated mAb was injected into female mice bearing HER2-GFP breast cancer subcutaneous xenografts.